(Q37464722)

20 August 2017

1 reference

title

The link between obesity and albuminuria: adiponectin and podocyte dysfunction (English)

1 reference

20 August 2017

0 references

Kumar Sharma

1

1 reference

PubMed ID

19404275

20 August 2017

language of work or name

English

0 references

publication date

29 April 2009

1 reference

20 August 2017

1 reference

20 August 2017

76

1 reference

20 August 2017

2

1 reference

20 August 2017

145-148

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2009.137

20 August 2017

0 references

cites work

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Cystatin C and the risk of death and cardiovascular events among elderly persons

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Importance of low-grade albuminuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Microalbuminuria as an early marker for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Renal injury in the extremely obese patients with normal renal function.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Structural and functional changes in the kidneys of high-fat diet-induced obese mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Adipose tissue as an endocrine organ

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Endocrinology of adipose tissue - an update

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Leptin and renal fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptake and TGF-beta type II receptor expression

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Association of plasma resistin with glomerular filtration rate and albuminuria in hypertensive adults

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

The helix-loop-helix factors Id3 and E47 are novel regulators of adiponectin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Adiponectin secretion and response to pioglitazone is depot dependent in cultured human adipose tissue

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Plasma adiponectin levels and risk of myocardial infarction in men.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Future adverse cardiac events can be predicted by persistently low plasma adiponectin concentrations in men and marked reductions of adiponectin in women after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Association of serum adiponectin levels with all-cause mortality in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Adiponectin: A novel adipokine linking adipocytes and vascular function

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

The adiponectin receptors AdipoR1 and AdipoR2 activate ERK1/2 through a Src/Ras-dependent pathway and stimulate cell growth

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Differential impacts of adiponectin on low-grade albuminuria between obese and nonobese persons without diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Role of the VEGF--a signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

VEGF inhibition and renal thrombotic microangiopathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Controversies in nephrology: response to 'renal albumin handling, facts, and artifacts'

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.137

7 January 2021

Identifiers

DOI

10.1038/KI.2009.137

1 reference

PubMed ID

19404275

Dimensions Publication ID

20 August 2017

0 references

1 reference

PubMed ID

19404275